Gefitinib in front line treatment of patients with NSCLC in the Czech Republic: Analysis of 113 patients

J. Skrickova, Z. Bortlicek, K. Hejduk, M. Pesek, V. Kolek, L. Koubkova, M. Tomiskova, J. Roubec, L. Havel, F. Salajka, I. Grygarkova, M. Hrnciarik, M. Satankova, Z. Povolna, M. Cernovska, M. Marel, M. Vasakova (Brno, Plzen, Olomouc, Praha, Ostrava, Hradec Kralove, Czech Republic)

Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Session: Therapy of thoracic tumours: clinical trials and case series
Session type: Thematic Poster Session
Number: 2721
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Skrickova, Z. Bortlicek, K. Hejduk, M. Pesek, V. Kolek, L. Koubkova, M. Tomiskova, J. Roubec, L. Havel, F. Salajka, I. Grygarkova, M. Hrnciarik, M. Satankova, Z. Povolna, M. Cernovska, M. Marel, M. Vasakova (Brno, Plzen, Olomouc, Praha, Ostrava, Hradec Kralove, Czech Republic). Gefitinib in front line treatment of patients with NSCLC in the Czech Republic: Analysis of 113 patients. Eur Respir J 2014; 44: Suppl. 58, 2721

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Second primary lung cancer in squamous NSCLC patients: The Nancy Biobank's database
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Safety and efficacy of erlotinib in patients with squamous cell lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014

Predictors of lung cancer patients delay time in Serbia - a cross-sectional study
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014


Comorbitities, responses and survival in pts with NSCLC
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

EGFR mutation diagnostic program for NSCLC patients in Poland between 2011-2014
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015

Survival in lung cancer: Associated factors in Tunisian patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015


Lung cancer in patients before the age of 45: A retrospective analysis of 62 patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015

Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

Methilation status in EBUS-NA samples of lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

The effect of socioeconomic deprivation on non-small cell lung cancer survival in North East Essex
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

ALK/EML4 translocation in non-squamous NSCLC and their predictors
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Metabolomic analysis of serum samples from patients with lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014


Lung cancer in England: Trends in survival over the duration of the national lung cancer audit
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Integrative analysis of DNA copy number in metastatic NSCLC identifies drug sensitivity to Afatinib
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Epidemiological changes of patients with lung cancer over Years
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013


Lung cancer in women: A seven years study in Eastern Algeria
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Lung cancer in women: What are particularities?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Lung cancer in women: Is it different?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014


Lung cancer, has it changed in the last ten years?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015